3<b></b>-Hydroxysterol <b>Δ</b>24-Reductase Promotes Ovarian Cancer Progression by Activating the TGF-<b></b>1/Smad2/3 Signaling Pathway
DHCR24 contributes to ovarian cancer progression by upregulating the TGF-β1 pathway, highlighting its potential as a therapeutic target in ovarian cancer.
Authors
- Zhen Huang (ORCID: https://orcid.org/0000-0003-4819-373X)
- Zhaoning Duan (ORCID: https://orcid.org/0000-0002-4551-1176)
- Wenjing Liao (ORCID: https://orcid.org/0000-0003-2309-3839)
- L. Wang (ORCID: https://orcid.org/0000-0001-6133-5013)
- Yimin Liu (ORCID: https://orcid.org/0000-0002-5050-1642)
- Haoyue Liu (ORCID: https://orcid.org/0000-0002-5510-5024)
- Liangdan Tang (ORCID: https://orcid.org/0000-0002-4882-6579)
- Z.-X. Zou
Institutions
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
- Published
- 2025-01-01
- DOI
- https://doi.org/10.32604/or.2025.065451
- Primary Topic
- Hormonal Regulation and Hypertension
- Type
- article
- Field-Weighted Citation Impact
- 0.00